Cite Filings / AVTX / 0001628280-23-034690

Feed Companies Filings Check

Sign in

DEFA14A

Proxy Materials

Avalo Therapeutics, Inc. Filed 2023-10-19 Acc 0001628280-23-034690

Documents 1

DEFA14A Proxy Materials , avtx-additionalmaterialsdea.htm

Around this filing

2023-12-07 DEFA14A Proxy Materials
2023-10-19 ARS Annual Report to Security Holders
2023-10-19 DEFA14A Proxy Materials
2023-10-19 DEF 14A Proxy Statement
2023-10-17 8-K Bylaws or fiscal year change
2022-04-25 DEFA14A Proxy Materials

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading avtx-additionalmaterialsdea.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…